.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Evidence for progesterone in recurrent spontaneous preterm birth is strongest in women with a short cervix, whereas benefit is much less consistent when cervical length is normal. Recent randomized studies have therefore refined earlier broad recommendations and emphasize phenotype-specific prevention. For obstetricians, the practical lesson is to distinguish a history-based risk factor from a current anatomical biomarker. Women with prior spontaneous preterm birth may need serial cervical-length assessment and individualized preventive planning rather than automatic progesterone for everyone. The study illustrates how treatment recommendations can change as higher-quality trials challenge assumptions based on older observational data. Shared decision-making should include prior obstetric history, cervical findings and alternative preventive measures such as cerclage when indicated.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Evidence for progesterone in recurrent spontaneous preterm birth is strongest in women with a short cervix, whereas benefit is much less consistent when cervical length is normal. Recent randomized studies have therefore refined earlier broad recommendations and emphasize phenotype-specific prevention. For obstetricians, the practical lesson is to distinguish a history-based risk factor from a current anatomical biomarker. Women with prior spontaneous preterm birth may need serial cervical-length assessment and individualized preventive planning rather than automatic progesterone for everyone. The study illustrates how treatment recommendations can change as higher-quality trials challenge assumptions based on older observational data. Shared decision-making should include prior obstetric history, cervical findings and alternative preventive measures such as cerclage when indicated.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
